The chemistry and metabolism of arsenic

Arsenic: Exposure Sources, Health Risks, and Mechanisms of Toxicity

Volumn , Issue , 2015, Pages 81-109

  Thomas, David J ^a  

^a U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

Arsenic biomethylation; Arsenic metabolism; Methylated thioarsenicals; Organic arsenicals

Indexed keywords

ARSENIC; ATOMS; PHYSIOLOGY;

AGGREGATE EXPOSURE; BIOMETHYLATION; INORGANIC ARSENIC; METABOLIC PROCESS; METHYLATED THIOARSENICALS; ORGANIC ARSENICALS; OXIDATION STATE; TOXICOLOGICAL SIGNIFICANCE;

METABOLISM;

EID: 85018225206     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781118876992.ch4     Document Type: Chapter

References (155)

1. B.M. Adair, T. Moore, S.D. Conklin, J.T. Creed, D.C. Wolf, D.J. Thomas, Tissue distribution and urinary excretion of dimethylated arsenic and its metabolites in dimethylarsinic acid-or arsenate-treated rats. Toxicol. Appl. Pharmacol. 222 (2007) 235-242.
2. A.A. Ajees, K. Marapakala, C. Packianathan, B. Sankaran, B.P. Rosen, Structure of an As(III) S-adenosylmethionine methyltransferase: insights into the mechanism of arsenic biotransformation. Biochemistry 51 (2012) 5476-5485.
3. C. Almela, J.M. Laparra, D. Velez, R. Barbera, R. Farre, R. Montoro, Arsenosugars in raw and cooked edible seaweed: characterization and bioaccessibility. J. Agric. Food Chem. 53 (2005) 7344-7351.
4. H.V. Aposhian, E.S. Gurzau, X.C. Le, A. Gurzau, S.M. Healy, X. Lu, M. Ma, L. Yip, R.A. Zakharyan, R.M. Maiorino, R.C. Dart, M.G. Tircus, D. Gonzalez-Ramirez, D.L. Morgan, D. Avram, M.M. Aposhian, Occurrence of monomethylarsonous acid in urine of humans exposed to inorganic arsenic. Chem. Res. Toxicol. 13 (2000) 693-697.
5. U. Arroyo-Abad, J. Mattusch, S. Mothes, M. Moder, R. Wennrich, M.P. Elizalde-Gonzalez, F.M. Matysik, Detection of arsenic-containing hydrocarbons in canned cod liver tissue. Talanta 82 (2010) 38-43.
6. K.A. Bailey, S.D. Hester, G.W. Knapp, R.D. Owen, S.F. Thai, Gene expression of normal human epidermal keratinocytes modulated by trivalent arsenicals. Mol. Carcinog. 49 (2010) 981-998.
7. M. Bartel, F. Ebert, L. Leffers, U. Karst, T. Schwerdtle, Toxicological characterization of the inorganic and organic arsenic metabolite thio-DMA in cultured human lung cells. J. Toxicol. 2011 (2011) 373141.
8. R.S. Braman, C.C. Foreback, Methylated forms of arsenic in the environment. Science 182 (1973) 1247-1249.
9. T.G. Bredfeldt, B. Jagadish, K.E. Eblin, E.A. Mash, A.J. Gandolfi, Monomethylarsonous acid induces transformation of human bladder cells. Toxicol. Appl. Pharmacol. 216 (2006) 69-79.
10. R.M. Brown, D. Newton, C.J. Pickford, J.C. Sherlock, Human metabolism of arsenobetaine ingested with fish. Hum. Exp. Toxicol. 9 (1990) 41-46.
11. J.P. Buchet, R. Lauwerys, Study of inorganic arsenic methylation by rat liver in vitro: relevance for the interpretation of observations in man. Arch. Toxicol. 57 (1985) 125-129.
12. J.P. Buchet, R. Lauwerys, Role of thiols in the in-vitro methylation of inorganic arsenic by rat liver cytosol. Biochem. Pharmacol. 37 (1988) 3149-3153.
13. J.P. Buchet, R. Lauwerys, H. Roels, Comparison of the urinary excretion of arsenic metabolites after a single oral dose of sodium arsenite, monomethylarsonate, or dimethylarsinate in man. Int. Arch. Occup. Environ. Health 48 (1981) 71-79.
14. J.P. Buchet, R. Lauwerys, H. Roels, Urinary excretion of inorganic arsenic and its metabolites after repeated ingestion of sodium metaarsenite by volunteers. Int. Arch. Occup. Environ. Health 48 (1981) 111-118.
15. J.P. Buchet, J. Pauwels, R. Lauwerys, Assessment of exposure to inorganic arsenic following ingestion of marine organisms by volunteers. Environ. Res. 66 (1994) 44-51.
16. G. Caumette, I. Koch, K.J. Reimer, Arsenobetaine formation in plankton: a review of studies at the base of the aquatic food chain. J. Environ. Monit. 14 (2012) 2841-2853.
17. F. Challenger, Biological methylation. Sci. Prog. 35 (1947) 396-416.
18. F. Challenger, Biological methylation. Adv. Enzymol. Relat. Subj. Biochem. 12 (1951) 429-491.
19. T.G. Chasteen, R. Bentley, Historic review: Frederick Challenger, 1887-1983: chemist and biochemist. Appl. Organomet. Chem. 17 (2003) 201-211.
20. B. Chen, L.L. Arnold, S.M. Cohen, D.J. Thomas, X.C. Le, Mouse arsenic (+3 oxidation state) methyltransferase genotype affects metabolism and tissue dosimetry of arsenicals after arsenite administration in drinking water. Toxicol. Sci. 124 (2011) 320-326.
21. N.C. Chen, F. Yang, L.M. Capecci, Z. Gu, A.I. Schafer, W. Durante, X.F. Yang, H. Wang, Regulation of homocysteine metabolism and methylation in human and mouse tissues. FASEB J. 24 (2010) 2804-2817.
22. M.K. Chern, R. Pietruszko, Evidence for mitochondrial localization of betaine aldehyde dehydrogenase in rat liver: purification, characterization, and comparison with human cytoplasmic E3 isozyme. Biochem. Cell Biol. 77 (1999) 179-187.
23. A. Christakopoulos, H. Norin, M. Sandstrom, H. Thor, P. Moldeus, R. Ryhage, Cellular metabolism of arsenocholine. J. Appl. Toxicol. 8 (1988) 119-127.
24. S.M. Cohen, T. Ohnishi, L.L. Arnold, X.C. Le, Arsenic-induced bladder cancer in an animal model. Toxicol. Appl. Pharmacol. 222 (2007) 258-263.
25. S.D. Conklin, A.H. Ackerman, M.W. Fricke, P.A. Creed, J.T. Creed, M.C. Kohan, K. Herbin-Davis, D.J. Thomas, In vitro biotransformation of an arsenosugar by mouse anaerobic cecal microflora and cecal tissue as examined using IC-ICP-MS and LC-ESIMS/ MS. Analyst 131 (2006) 648-655.
26. S.D. Conklin, M.W. Fricke, P.A. Creed, J.T. Creed, Investigation of the pH effects on the formation of methylated thio-arsenicals, and the effects of pH and temperature on their stability. J. Anal. At. Spectrom. 23 (2008) 711-716.
27. E.A. Crecelius, Changes in the chemical speciation of arsenic following ingestion by man. Environ. Health Perspect. 19 (1977) 147-150.
28. W.R. Cullen, Is Arsenic an Aphrodisiac? The Sociochemistry of an Element, The Royal Society of Chemistry, Cambridge, 2008.
29. W.R. Cullen, Chemical mechanism of arsenic biomethylation. Chem. Res. Toxicol. 27 (2014) 457-461.
30. W.R. Cullen, B.C. McBride, J. Reglinski, The reduction of trimethylarsine oxide to trimethylarsine by thiols: a mechanistic model for the biological reduction of arsenicals. J. Inorg. Biochem. 21 (1984) 45-60.
31. J. Currier, R.J. Saunders, L. Ding, W. Bodnar, P. Cable, T. Matousek, J.T. Creed, M. Styblo, Comparative oxidation state specific analysis of arsenic species by highperformance liquid chromatography-inductively coupled plasma-mass spectrometry and hydride generation-cryotrapping-atomic absorption spectrometry. J. Anal. At. Spectrom. 28 (2013) 843-852.
32. J.M. Currier, M. Svoboda, D.P. de Moraes, T. Matousek, J. Dedina, M. Styblo, Direct analysis of methylated trivalent arsenicals in mouse liver by hydride generation-cryotrapping-atomic absorption spectrometry. Chem. Res. Toxicol. 24 (2011) 478-480.
33. J.M. Currier, M. Svoboda, T. Matousek, J. Dedina, M. Styblo, Direct analysis and stability of methylated trivalent arsenic metabolites in cells and tissues. Metallomics 3 (2011) 1347-1354.
34. L.M. Del Razo, G.G. Garcia-Vargas, O.L. Valenzuela, E.H. Castellanos, L.C. Sanchez-Pena, J.M. Currier, Z. Drobna, D. Loomis, M. Styblo, Exposure to arsenic in drinking water is associated with increased prevalence of diabetes: a cross-sectional study in the Zimapan and Lagunera regions in Mexico. Environ. Health 10 (2011) 73.
35. V.M. Dembitsky, D.O. Levitsky, Arsenolipids. Prog. Lipid Res. 43 (2004) 403-448.
36. B. Deplancke, K. Finster, W.V. Graham, C.T. Collier, J.E. Thurmond, H.R. Gaskins, Gastrointestinal and microbial responses to sulfate-supplemented drinking water in mice. Exp. Biol. Med. (Maywood) 228 (2003) 424-433.
37. V. Devesa, A. Loos, M.A. Suner, D. Velez, A. Feria, A. Martinez, R. Montoro, Y. Sanz, Transformation of organoarsenical species by the microflora of freshwater crayfish. J. Agric. Food Chem. 53 (2005) 10297-10305.
38. L. Ding, R.J. Saunders, Z. Drobna, F.S. Walton, P. Xun, D.J. Thomas, M. Styblo, Methylation of arsenic by recombinant human wild-type arsenic (+3 oxidation state) methyltransferase and its methionine 287 threonine (M287T) polymorph: role of glutathione. Toxicol. Appl. Pharmacol. 264 (2012) 121-130.
39. P.R. Dodmane, L.L. Arnold, K.L. Pennington, D.J. Thomas, S.M. Cohen, Effect of dietary treatment with dimethylarsinous acid (DMA(III)) on the urinary bladder epithelium of arsenic (+3 oxidation state) methyltransferase (As3mt) knockout and C57BL/6 wild type female mice. Toxicology 305 (2013) 130-135.
40. C. Douillet, J. Currier, J. Saunders, W.M. Bodnar, T. Matousek, M. Styblo, Methylated trivalent arsenicals are potent inhibitors of glucose stimulated insulin secretion by murine pancreatic islets. Toxicol. Appl. Pharmacol. 267 (2013) 11-15.
41. Z. Drobna, H. Naranmandura, K.M. Kubachka, B.C. Edwards, K. Herbin-Davis, M. Styblo, X.C. Le, J.T. Creed, N. Maeda, M.F. Hughes, D.J. Thomas, Disruption of the arsenic (+3 oxidation state) methyltransferase gene in the mouse alters the phenotype for methylation of arsenic and affects distribution and retention of orally administered arsenate. Chem. Res. Toxicol. 22 (2009) 1713-1720.
42. Z. Drobna, S.B. Waters, V. Devesa, A.W. Harmon, D.J. Thomas, M. Styblo, Metabolism and toxicity of arsenic in human urothelial cells expressing rat arsenic (+3 oxidation state)-methyltransferase. Toxicol. Appl. Pharmacol. 207 (2005) 147-159.
43. Z. Drobna, W. Xing, D.J. Thomas, M. Styblo, shRNA silencing of AS3MT expression minimizes arsenic methylation capacity of HepG2 cells. Chem. Res. Toxicol. 19 (2006) 894-898.
44. J.L. Ellis, S.D. Conklin, C.M. Gallawa, K.M. Kubachka, A.R. Young, P.A. Creed, J.A. Caruso, J.T. Creed, Complementary molecular and elemental detection of speciated thioarsenicals using ESI-MS in combination with a xenon-based collision-cell ICP-MS with application to fortified NIST freeze-dried urine. Anal. Bioanal. Chem. 390 (2008) 1731-1737.
45. C. Escudero-Lourdes, M.K. Medeiros, M.C. Cardenas-Gonzalez, S.M. Wnek, J.A. Gandolfi, Low level exposure to monomethyl arsonous acid-induced the over-production of inflammation-related cytokines and the activation of cell signals associated with tumor progression in a urothelial cell model. Toxicol. Appl. Pharmacol. 244 (2010) 162-173.
46. J. Feldmann, K. John, P. Pengprecha, Arsenic metabolism in seaweed-eating sheep from Northern Scotland. Fresenius J. Anal. Chem. 368 (2000) 116-121.
47. D.E. Fomenko, W. Xing, B.M. Adair, D.J. Thomas, V.N. Gladyshev, High-throughput identification of catalytic redox-active cysteine residues. Science 315 (2007) 387-389.
48. M. Fontcuberta, J. Calderon, J.R. Villalbi, F. Centrich, S. Portana, A. Espelt, J. Duran, M. Nebot, Total and inorganic arsenic in marketed food and associated health risks for the Catalan (Spain) population. J. Agric. Food Chem. 59 (2011) 10013-10022.
49. K.A. Francesconi, Arsenic species in seafood: origin and human health implications. Pure Appl. Chem. 82 (2010) 373-381.
50. K.A. Francesconi, R. Tanggaar, C.J. McKenzie, W. Goessler, Arsenic metabolites in human urine after ingestion of an arsenosugar. Clin. Chem. 48 (2002) 92-101.
51. M. Fu, W. Zhang, L. Wu, G. Yang, H. Li, R. Wang, Hydrogen sulfide (H2S) metabolism in mitochondria and its regulatory role in energy production. Proc. Natl. Acad. Sci. U. S. A. 109 (2012) 2943-2948.
52. S. Fukuda, M. Terasawa, K. Shiomi, Phosphatidylarsenocholine, one of the major arsenolipids in marine organisms: synthesis and metabolism in mice. Food Chem. Toxicol. 49 (2011) 1598-1603.
53. J. Furne, A. Saeed, M.D. Levitt, Whole tissue hydrogen sulfide concentrations are orders of magnitude lower than presently accepted values. Am. J. Physiol. Regul. Integr. Comp. Physiol. 295 (2008) R1479-R1485.
54. B.M. Gamble, P.A. Gallagher, J.A. Shoemaker, X. Wei, C.A. Schwegel, J.T. Creed, An investigation of the chemical stability of arsenosugars in simulated gastric juice and acidic environments using IC-ICP-MS and IC-ESI-MS/MS. Analyst 127 (2002) 781-785.
55. E.A. Garcia-Montalvo, O.L. Valenzuela, L.C. Sanchez-Pena, A. Albores, L.M. Del Razo, Dose-dependent urinary phenotype of inorganic arsenic methylation in mice with a focus on trivalent methylated metabolites. Toxicol. Mech. Methods 21 (2011) 649-655.
56. B. Georis, A. Cardenas, J.P. Buchet, R. Lauwerys, Inorganic arsenic methylation by rat tissue slices. Toxicology 63 (1990) 73-84.
57. Z. Gregus, A. Gyurasics, I. Csanaky, Biliary and urinary excretion of inorganic arsenic: monomethylarsonous acid as a major biliary metabolite in rats. Toxicol. Sci. 56 (2000) 18-25.
58. L.L. Hall, S.E. George, M.J. Kohan, M. Styblo, D.J. Thomas, In vitro methylation of inorganic arsenic in mouse intestinal cecum. Toxicol. Appl. Pharmacol. 147 (1997) 101-109.
59. H.R. Hansen, M. Jaspars, J. Feldmann, Arsinothioyl-sugars produced by in vitro incubation of seaweed extract with liver cytosol analysed by HPLC coupled simultaneously to ES-MS and ICP-MS. Analyst 129 (2004) 1058-1064.
60. H.R. Hansen, R. Pickford, J. Thomas-Oates, M. Jaspars, J. Feldmann, 2-Dimethylarsinothioyl acetic acid identified in a biological sample: the first occurrence of a mammalian arsinothioyl metabolite. Angew. Chem. Int. Ed. Engl. 43 (2004) 337-340.
61. F. Harari, K. Engstrom, G. Concha, G. Colque, M. Vahter, K. Broberg, N-6-adeninespecific DNA methyltransferase 1 (N6AMT1) polymorphisms and arsenic methylation in Andean women. Environ. Health Perspect. 121 (2013) 797-803.
62. C.F. Harrington, E.I. Brima, R.O. Jenkins, Biotransformation of arsenobetaine by microorganisms from the human gastrointestinal tract. Chem. Speciat. Bioavailab. 20 (2008) 173-180.
63. T. Hayakawa, Y. Kobayashi, X. Cui, S. Hirano, A new metabolic pathway of arsenite: arsenic-glutathione complexes are substrates for human arsenic methyltransferase Cyt19. Arch. Toxicol. 79 (2005) 183-191.
64. A. Hernandez-Zavala, T. Matousek, Z. Drobna, D.S. Paul, F. Walton, B.M. Adair, D. Jiri, D.J. Thomas, M. Styblo, Speciation analysis of arsenic in biological matrices by automated hydride generation-cryotrapping-atomic absorption spectrometry with multiple microflame quartz tube atomizer (multiatomizer). J. Anal. At. Spectrom. 23 (2008) 342-351.
65. S. Hirata, H. Toshimitsu, Determination of arsenic species and arsenosugars in marine samples by HPLC-ICP-MS. Anal. Bioanal. Chem. 383 (2005) 454-460.
66. M.F. Hughes, B.C. Edwards, K.M. Herbin-Davis, J. Saunders, M. Styblo, D.J. Thomas, Arsenic (+3 oxidation state) methyltransferase genotype affects steady-state distribution and clearance of arsenic in arsenate-treated mice. Toxicol. Appl. Pharmacol. 249 (2010) 217-223.
67. R.O. Jenkins, A.W. Ritchie, J.S. Edmonds, W. Goessler, N. Molenat, D. Kuehnelt, C.F. Harrington, P.G. Sutton, Bacterial degradation of arsenobetaine via dimethylarsinoylacetate. Arch. Microbiol. 180 (2003) 142-150.
68. T.J. Jensen, P. Novak, S.M. Wnek, A.J. Gandolfi, B.W. Futscher, Arsenicals produce stable progressive changes in DNA methylation patterns that are linked to malignant transformation of immortalized urothelial cells. Toxicol. Appl. Pharmacol. 241 (2009) 221-229.
69. D.A. Kalman, R.L. Dills, C. Steinmaus, M. Yunus, A.F. Khan, M.M. Prodhan, Y. Yuan, A.H. Smith, Occurrence of trivalent monomethyl arsenic and other urinary arsenic species in a highly exposed juvenile population in Bangladesh. J. Expo. Sci. Environ. Epidemiol. 24 (2014) 113-120.
70. H. Kimura, Metabolic turnover of hydrogen sulfide. Front. Physiol. 3 (2012) 101.
71. K.M. Kubachka, M.C. Kohan, S.D. Conklin, K. Herbin-Davis, J.T. Creed, D.J. Thomas, In vitro biotransformation of dimethylarsinic acid and trimethylarsine oxide by anaerobic microflora of mouse cecum analyzed by HPLC-ICP-MS and HPLC-ESI-MS. J. Anal. At. Spectrom. 24 (2009) 1062-1068.
72. K.M. Kubachka, M.C. Kohan, K. Herbin-Davis, J.T. Creed, D.J. Thomas, Exploring the in vitro formation of trimethylarsine sulfide from dimethylthioarsinic acid in anaerobic microflora of mouse cecum using HPLC-ICP-MS and HPLC-ESI-MS. Toxicol. Appl. Pharmacol. 239 (2009) 137-143.
73. C.A. Lammon, X.C. Le, R.D. Hood, Pretreatment with periodate-oxidized adenosine enhances developmental toxicity of inorganic arsenic in mice. Birth Defects Res. B Dev. Reprod. Toxicol. 68 (2003) 335-343.
74. X.C. Le, M. Ma, W.R. Cullen, H.V. Aposhian, X. Lu, B. Zheng, Determination of monomethylarsonous acid, a key arsenic methylation intermediate, in human urine. Environ. Health Perspect. 108 (2000) 1015-1018.
75. L. Leffers, F. Ebert, M.S. Taleshi, K.A. Francesconi, T. Schwerdtle, In vitro toxicological characterization of two arsenosugars and their metabolites. Mol. Nutr. Food Res. 57 (2013) 1270-1282.
76. L. Leffers, M. Unterberg, M. Bartel, C. Hoppe, I. Pieper, J. Stertmann, F. Ebert, H.U. Humpf, T. Schwerdtle, In vitro toxicological characterisation of the S-containing arsenic metabolites thio-dimethylarsinic acid and dimethylarsinic glutathione. Toxicology 305 (2013) 109-119.
77. B. Lehmann, E. Ebeling, C. Alsen-Hinrichs, Kinetics of arsenic in human blood after a fish meal. Gesundheitswesen 63 (2001) 42-48.
78. M.D. Levitt, M.S. Abdel-Rehim, J. Furne, Free and acid-labile hydrogen sulfide concentrations in mouse tissues: anomalously high free hydrogen sulfide in aortic tissue. Antioxid. Redox Signal. 15 (2011) 373-378.
79. L. Li, P. Rose, P.K. Moore, Hydrogen sulfide and cell signaling. Annu. Rev. Pharmacol. Toxicol. 51 (2011) 169-187.
80. W. Li, H. Wanibuchi, E.I. Salim, S. Yamamoto, K. Yoshida, G. Endo, S. Fukushima, Promotion of NCI-Black-Reiter male rat bladder carcinogenesis by dimethylarsinic acid an organic arsenic compound. Cancer Lett. 134 (1998) 29-36.
81. S. Lin, L.M. Del Razo, M. Styblo, C. Wang, W.R. Cullen, D.J. Thomas, Arsenicals inhibit thioredoxin reductase in cultured rat hepatocytes. Chem. Res. Toxicol. 14 (2001) 305-311.
82. S. Lin, Q. Shi, F.B. Nix, M. Styblo, M.A. Beck, K.M. Herbin-Davis, L.L. Hall, J.B. Simeonsson, D.J. Thomas, A novel S-adenosyl-L-methionine:arsenic(III) methyltransferase from rat liver cytosol. J. Biol. Chem. 277 (2002) 10795-10803.
83. X. Lu, L.L. Arnold, S.M. Cohen, W.R. Cullen, X.C. Le, Speciation of dimethylarsinous acid and trimethylarsine oxide in urine from rats fed with dimethylarsinic acid and dimercaptopropane sulfonate. Anal. Chem. 75 (2003) 6463-6468.
84. M. Ma, X.C. Le, Effect of arsenosugar ingestion on urinary arsenic speciation. Clin. Chem. 44 (1998) 539-550.
85. B.K. Mandal, Y. Ogra, K.T. Suzuki, Identification of dimethylarsinous and monomethylarsonous acids in human urine of the arsenic-affected areas in West Bengal, India. Chem. Res. Toxicol. 14 (2001) 371-378.
86. E. Marafante, M. Vahter, The effect of methyltransferase inhibition on the metabolism of [74As]arsenite in mice and rabbits. Chem. Biol. Interact. 50 (1984) 49-57.
87. E. Marafante, M. Vahter, J. Envall, The role of the methylation in the detoxication of arsenate in the rabbit. Chem. Biol. Interact. 56 (1985) 225-238.
88. K. Marapakala, J. Qin, B.P. Rosen, Identification of catalytic residues in the As(III) S-adenosylmethionine methyltransferase. Biochemistry 51 (2012) 944-951.
89. M.J. Mass, A. Tennant, B.C. Roop, W.R. Cullen, M. Styblo, D.J. Thomas, A.D. Kligerman, Methylated trivalent arsenic species are genotoxic. Chem. Res. Toxicol. 14 (2001) 355-361.
90. M. Medani, D. Collins, N.G. Docherty, A.W. Baird, P.R. O'Connell, D.C. Winter, Emerging role of hydrogen sulfide in colonic physiology and pathophysiology. Inflamm. Bowel Dis. 17 (2011) 1620-1625.
91. M. Medeiros, X. Zheng, P. Novak, S.M. Wnek, V. Chyan, C. Escudero-Lourdes, A.J. Gandolfi, Global gene expression changes in human urothelial cells exposed to low-level monomethylarsonous acid. Toxicology 291 (2012) 102-112.
92. S.R. Meno, R. Nelson, K.J. Hintze, W.T. Self, Exposure to monomethylarsonous acid (MMA(III)) leads to altered selenoprotein synthesis in a primary human lung cell model. Toxicol. Appl. Pharmacol. 239 (2009) 130-136.
93. S. Miyashita, S. Fujiwara, M. Tsuzuki, T. Kaise, Rapid biotransformation of arsenate into oxo-arsenosugars by a freshwater unicellular green alga, Chlamydomonas reinhardtii. Biosci. Biotechnol. Biochem. 75 (2011) 522-530.
94. S.i. Miyashita, S. Fujiwara, M. Tsuzuki, T. Kaise, Cyanobacteria produce arsenosugars. Environ. Chem. 9 (2012) 474-484.
95. M. Molin, S.M. Ulven, L. Dahl, V.H. Telle-Hansen, M. Holck, G. Skjegstad, O. Ledsaak, J.J. Sloth, W. Goessler, A. Oshaug, J. Alexander, D. Fliegel, T.A. Ydersbond, H.M. Meltzer, Humans seem to produce arsenobetaine and dimethylarsinate after a bolus dose of seafood. Environ. Res. 112 (2012) 28-39.
96. T. Murai, H. Iwata, T. Otoshi, G. Endo, S. Horiguchi, S. Fukushima, Renal lesions induced in F344/DuCrj rats by 4-weeks oral administration of dimethylarsinic acid. Toxicol. Lett. 66 (1993) 53-61.
97. H. Naranmandura, M.W. Carew, S. Xu, J. Lee, E.M. Leslie, M. Weinfeld, X.C. Le, Comparative toxicity of arsenic metabolites in human bladder cancer EJ-1 cells. Chem. Res. Toxicol. 24 (2011) 1586-1596.
98. H. Naranmandura, Y. Ogra, K. Iwata, J. Lee, K.T. Suzuki, M. Weinfeld, X.C. Le, Evidence for toxicity differences between inorganic arsenite and thioarsenicals in human bladder cancer cells. Toxicol. Appl. Pharmacol. 238 (2009) 133-140.
99. H. Naranmandura, K. Rehman, X.C. Le, D.J. Thomas, Formation of methylated oxyarsenicals and thioarsenicals in wild-type and arsenic (+3 oxidation state) methyltransferase knockout mice exposed to arsenate. Anal. Bioanal. Chem. 405 (2013) 1885-1891.
100. H. Naranmandura, N. Suzuki, K.T. Suzuki, Trivalent arsenicals are bound to proteins during reductive methylation. Chem. Res. Toxicol. 19 (2006) 1010-1018.
101. H. Naranmandura, S. Xu, T. Sawata, W.H. Hao, H. Liu, N. Bu, Y. Ogra, Y.J. Lou, N. Suzuki, Mitochondria are the main target organelle for trivalent monomethylarsonous acid (MMA(III))-induced cytotoxicity. Chem. Res. Toxicol. 24 (2011) 1094-1103.
102. K.R. Olson, Hydrogen sulfide: both feet on the gas and none on the brake? Front. Physiol. 4 (2013) 2.
103. J.S. Petrick, F. Ayala-Fierro, W.R. Cullen, D.E. Carter, A.H. Vasken, Monomethylarsonous acid (MMA(III)) is more toxic than arsenite in Chang human hepatocytes. Toxicol. Appl. Pharmacol. 163 (2000) 203-207.
104. J.S. Petrick, B. Jagadish, E.A. Mash, H.V. Aposhian, Monomethylarsonous acid (MMA(III)) and arsenite: LD(50) in hamsters and in vitro inhibition of pyruvate dehydrogenase. Chem. Res. Toxicol. 14 (2001) 651-656.
105. T.S. Pinyayev, M.J. Kohan, K. Herbin-Davis, J.T. Creed, D.J. Thomas, Preabsorptive metabolism of sodium arsenate by anaerobic microbiota of mouse cecum forms a variety of methylated and thiolated arsenicals. Chem. Res. Toxicol. 24 (2011) 475-477.
106. B. Planer-Friedrich, E. Suess, A.C. Scheinost, D. Wallschlager, Arsenic speciation in sulfidic waters: reconciling contradictory spectroscopic and chromatographic evidence. Anal. Chem. 82 (2010) 10228-10235.
107. G. Raber, S. Khoomrung, M.S. Taleshi, J.S. Edmonds, K.A. Francesconi, Identification of arsenolipids with GC/MS. Talanta 78 (2009) 1215-1218.
108. R. Raml, W. Goessler, P. Traar, T. Ochi, K.A. Francesconi, Novel thioarsenic metabolites in human urine after ingestion of an arsenosugar, 2',3'-dihydroxypropyl 5-deoxy-5-dimethylarsinoyl-beta-D-riboside. Chem. Res. Toxicol. 18 (2005) 1444-1450.
109. R. Raml, G. Raber, A. Rumpler, T. Bauernhofer, W. Goessler, K.A. Francesconi, Individual variability in the human metabolism of an arsenic-containing carbohydrate, 2',3'-dihydroxypropyl 5-deoxy-5-dimethylarsinoyl-beta-D-riboside, a naturally occurring arsenical in seafood. Chem. Res. Toxicol. 22 (2009) 1534-1540.
110. R. Raml, A. Rumpler, W. Goessler, M. Vahter, L. Li, T. Ochi, K.A. Francesconi, Thiodimethylarsinate is a common metabolite in urine samples from arsenic-exposed women in Bangladesh. Toxicol. Appl. Pharmacol. 222 (2007) 374-380.
111. K. Rehman, Z. Chen, W.W. Wang, Y.W. Wang, A. Sakamoto, Y.F. Zhang, H. Naranmandura, N. Suzuki, Mechanisms underlying the inhibitory effects of arsenic compounds on protein tyrosine phosphatase (PTP). Toxicol. Appl. Pharmacol. 263 (2012) 273-280.
112. K. Rehman, H. Naranmandura, Arsenic metabolism and thioarsenicals. Metallomics 4 (2012) 881-892.
113. X. Ren, M. Aleshin, W.J. Jo, R. Dills, D.A. Kalman, C.D. Vulpe, M.T. Smith, L. Zhang, Involvement of N-6 adenine-specific DNA methyltransferase 1 (N6AMT1) in arsenic biomethylation and its role in arsenic-induced toxicity. Environ. Health Perspect. 119 (2011) 771-777.
114. E.H. Rogers, N. Chernoff, R.J. Kavlock, The teratogenic potential of cacodylic acid in the rat and mouse. Drug Chem. Toxicol. 4 (1981) 49-61.
115. A. Rumpler, J.S. Edmonds, M. Katsu, K.B. Jensen, W. Goessler, G. Raber, H. Gunnlaugsdottir, K.A. Francesconi, Arsenic-containing long-chain fatty acids in cod-liver oil: a result of biosynthetic infidelity? Angew. Chem. Int. Ed. Engl. 47 (2008) 2665-2667.
116. J. Scheer, S. Findenig, W. Goessler, K.A. Francesconi, B. Howard, J.G. Umans, J. Pollak, M. Tellez-Plaza, E.K. Silbergeld, E. Guallar, A. Navas-Acien, Arsenic species and selected metals in human urine: validation of HPLC/ICPMS and ICPMS procedures for a long-term population-based epidemiological study. Anal. Methods 4 (2012) 406-413.
117. E. Schmeisser, W. Goessler, K.A. Francesconi, Human metabolism of arsenolipids present in cod liver. Anal. Bioanal. Chem. 385 (2006) 367-376.
118. E. Schmeisser, A. Rumpler, M. Kollroser, G. Rechberger, W. Goessler, K.A. Francesconi, Arsenic fatty acids are human urinary metabolites of arsenolipids present in cod liver. Angew. Chem. Int. Ed. Engl. 45 (2005) 150-154.
119. J. Shen, H. Wanibuchi, E.I. Salim, M. Wei, A. Kinoshita, K. Yoshida, G. Endo, S. Fukushima, Liver tumorigenicity of trimethylarsine oxide in male Fischer 344 rats- association with oxidative DNA damage and enhanced cell proliferation. Carcinogenesis 24 (2003) 1827-1835.
120. S. Singh, R. Banerjee, PLP-dependent H(2)S biogenesis. Biochim. Biophys. Acta 1814 (2011) 1518-1527.
121. S. Singh, D. Padovani, R.A. Leslie, T. Chiku, R. Banerjee, Relative contributions of cystathionine beta-synthase and gamma-cystathionase to H2S biogenesis via alternative trans-sulfuration reactions. J. Biol. Chem. 284 (2009) 22457-22466.
122. T.J. Smith, E.A. Crecelius, J.C. Reading, Airborne arsenic exposure and excretion of methylated arsenic compounds. Environ. Health Perspect. 19 (1977) 89-93.
123. X. Song, Z. Geng, J. Zhu, C. Li, X. Hu, N. Bian, X. Zhang, Z. Wang, Structure-function roles of four cysteine residues in the human arsenic (+3 oxidation state) methyltransferase (hAS3MT) by site-directed mutagenesis. Chem. Biol. Interact. 179 (2009) 321-328.
124. M.H. Stipanuk, J.E. Dominy, Jr., J.I. Lee, R.M. Coloso, Mammalian cysteine metabolism: new insights into regulation of cysteine metabolism. J. Nutr. 136 (2006) 1652S-1659S.
125. M. Styblo, L.M. Del Razo, L. Vega, D.R. Germolec, E.L. LeCluyse, G.A. Hamilton, W. Reed, C. Wang, W.R. Cullen, D.J. Thomas, Comparative toxicity of trivalent and pentavalent inorganic and methylated arsenicals in rat and human cells. Arch. Toxicol. 74 (2000) 289-299.
126. M. Styblo, S.V. Serves, W.R. Cullen, D.J. Thomas, Comparative inhibition of yeast glutathione reductase by arsenicals and arsenothiols. Chem. Res. Toxicol. 10 (1997) 27-33.
127. F. Suarez, J. Furne, J. Springfield, M. Levitt, Production and elimination of sulfurcontaining gases in the rat colon. Am. J. Physiol. 274 (1998) G727-G733.
128. E. Suess, D. Wallschlager, B. Planer-Friedrich, Stabilization of thioarsenates in ironrich waters. Chemosphere 83 (2011) 1524-1531.
129. S. Suzuki, L.L. Arnold, K.L. Pennington, B. Chen, H. Naranmandura, X.C. Le, S.M. Cohen, Dietary administration of sodium arsenite to rats: relations between dose and urinary concentrations of methylated and thio-metabolites and effects on the rat urinary bladder epithelium. Toxicol. Appl. Pharmacol. 244 (2010) 99-105.
130. M.S. Taleshi, J.S. Edmonds, W. Goessler, M.J. Ruiz-Chancho, G. Raber, K.B. Jensen, K.A. Francesconi, Arsenic-containing lipids are natural constituents of sashimi tuna. Environ. Sci. Technol. 44 (2010) 1478-1483.
131. M.S. Taleshi, K.B. Jensen, G. Raber, J.S. Edmonds, H. Gunnlaugsdottir, K.A. Francesconi, Arsenic-containing hydrocarbons: natural compounds in oil from the fish capelin, Mallotus villosus. Chem. Commun. (Camb.) 2008 (2008) 4706-4707.
132. W.H. Tang, Z. Wang, B.S. Levison, R.A. Koeth, E.B. Britt, X. Fu, Y. Wu, S.L. Hazen, Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. N. Engl. J. Med. 368 (2013) 1575-1584.
133. D.J. Thomas, J. Li, S.B. Waters, W. Xing, B.M. Adair, Z. Drobna, V. Devesa, M. Styblo, Arsenic (+3 oxidation state) methyltransferase and the methylation of arsenicals. Exp. Biol. Med. (Maywood) 232 (2007) 3-13.
134. D.J. Thomas, B.P. Rosen, Arsenic methyltransferases. in: R.H. Kretsinger, V.N. Uversky, E.A. Permyakov (Eds.), Encyclopedia of Metalloproteins, Springer, Berlin, 2013, pp. 138-143.
135. E.J. Tokar, B.A. Diwan, D.J. Thomas, M.P. Waalkes, Tumors and proliferative lesions in adult offspring after maternal exposure to methylarsonous acid during gestation in CD1 mice. Arch. Toxicol. 86 (2012) 975-982.
136. M. Vahter, E. Marafante, L. Dencker, Metabolism of arsenobetaine in mice, rats and rabbits. Sci. Total Environ. 30 (1983) 197-211.
137. M. Van Hulle, C. Zhang, B. Schotte, L. Mees, F. Vanhaecke, R. Vanholder, X.R. Zhang, R. Cornelis, Identification of some arsenic species in human urine and blood after ingestion of Chinese seaweed Laminaria. J. Anal. At. Spectrom. 19 (2004) 58-64.
138. V. Vitvitsky, O. Kabil, R. Banerjee, High turnover rates for hydrogen sulfide allow for rapid regulation of its tissue concentrations. Antioxid. Redox Signal. 17 (2012) 22-31.
139. F.S. Walton, A.W. Harmon, D.S. Paul, Z. Drobna, Y.M. Patel, M. Styblo, Inhibition of insulin-dependent glucose uptake by trivalent arsenicals: possible mechanism of arsenic-induced diabetes. Toxicol. Appl. Pharmacol. 198 (2004) 424-433.
140. S. Wang, X. Li, X. Song, Z. Geng, X. Hu, Z. Wang, Rapid equilibrium kinetic analysis of arsenite methylation catalyzed by recombinant human arsenic (+3 oxidation state) methyltransferase (hAS3MT). J. Biol. Chem. 287 (2012) 38790-38799.
141. Z. Wang, J. Zhou, X. Lu, Z. Gong, X.C. Le, Arsenic speciation in urine from acute promyelocytic leukemia patients undergoing arsenic trioxide treatment. Chem. Res. Toxicol. 17 (2004) 95-103.
142. S.B. Waters, V. Devesa, L.M. Del Razo, M. Styblo, D.J. Thomas, Endogenous reductants support the catalytic function of recombinant rat cyt19, an arsenic methyltransferase. Chem. Res. Toxicol. 17 (2004) 404-409.
143. S.B. Waters, V. Devesa, M.W. Fricke, J.T. Creed, M. Styblo, D.J. Thomas, Glutathione modulates recombinant rat arsenic (+3 oxidation state) methyltransferase-catalyzed formation of trimethylarsine oxide and trimethylarsine. Chem. Res. Toxicol. 17 (2004) 1621-1629.
144. N.L. Whitfield, E.L. Kreimier, F.C. Verdial, N. Skovgaard, K.R. Olson, Reappraisal of H2S/sulfide concentration in vertebrate blood and its potential significance in ischemic preconditioning and vascular signaling. Am. J. Physiol. Regul. Integr. Comp. Physiol. 294 (2008) R1930-R1937.
145. E. Wildfang, R.A. Zakharyan, H.V. Aposhian, Enzymatic methylation of arsenic compounds. VI. Characterization of hamster liver arsenite and methylarsonic acid methyltransferase activities in vitro. Toxicol. Appl. Pharmacol. 152 (1998) 366-375.
146. S.M. Wnek, T.J. Jensen, P.L. Severson, B.W. Futscher, A.J. Gandolfi, Monomethylarsonous acid produces irreversible events resulting in malignant transformation of a human bladder cell line following 12 weeks of low-level exposure. Toxicol. Sci. 116 (2010) 44-57.
147. S.M. Wnek, C.L. Kuhlman, J.M. Camarillo, M.K. Medeiros, K.J. Liu, S.S. Lau, A.J. Gandolfi, Interdependent genotoxic mechanisms of monomethylarsonous acid: role of ROS-induced DNA damage and poly(ADP-ribose) polymerase-1 inhibition in the malignant transformation of urothelial cells. Toxicol. Appl. Pharmacol. 257 (2011) 1-13.
148. R. Xie, W. Johnson, S. Spayd, G.S. Hall, B. Buckley, Arsenic speciation analysis of human urine using ion exchange chromatography coupled to inductively coupled plasma mass spectrometry. Anal. Chim. Acta 578 (2006) 186-194.
149. S. Yamamoto, Y. Konishi, T. Matsuda, T. Murai, M.A. Shibata, I. Matsui-Yuasa, S. Otani, K. Kuroda, G. Endo, S. Fukushima, Cancer induction by an organic arsenic compound, dimethylarsinic acid (cacodylic acid), in F344/DuCrj rats after pretreatment with five carcinogens. Cancer Res. 55 (1995) 1271-1276.
150. H. Yamauchi, B.A. Fowler in: J. O. Nriagu (Ed.), Arsenic in the Environment, Part II: Human Health and Ecosystem Effects, John Wiley & Sons, Inc., New York, 1994, pp. 35-43.
151. M. Yokohira, L.L. Arnold, K.L. Pennington, S. Suzuki, S. Kakiuchi-Kiyota, K. Herbin-Davis, D.J. Thomas, S.M. Cohen, Effect of sodium arsenite dose administered in the drinking water on the urinary bladder epithelium of female arsenic (+3 oxidation state) methyltransferase knockout mice. Toxicol. Sci. 121 (2011) 257-266.
152. K. Yoshida, K. Kuroda, Y. Inoue, H. Chen, H. Wanibuchi, S. Fukushima, G. Endo, Metabolites of arsenobetaine in rats: does decomposition of arsenobetaine occur in mammals? Appl. Organomet. Chem. 15 (2001) 271-276.
153. R. Zakharyan, Y. Wu, G.M. Bogdan, H.V. Aposhian, Enzymatic methylation of arsenic compounds: assay, partial purification, and properties of arsenite methyltransferase and monomethylarsonic acid methyltransferase of rabbit liver. Chem. Res. Toxicol. 8 (1995) 1029-1038.
154. R.A. Zakharyan, H.V. Aposhian, Enzymatic reduction of arsenic compounds in mammalian systems: the rate-limiting enzyme of rabbit liver arsenic biotransformation is MMA(V) reductase. Chem. Res. Toxicol. 12 (1999) 1278-1283.
155. R.A. Zakharyan, F. Ayala-Fierro, W.R. Cullen, D.M. Carter, H.V. Aposhian, Enzymatic methylation of arsenic compounds. VII. Monomethylarsonous acid (MMAIII) is the substrate for MMA methyltransferase of rabbit liver and human hepatocytes. Toxicol. Appl. Pharmacol. 158 (1999) 9-15.